# Recent Advances in Smart Stimulus-Responsive Hydrogels for Precision Drug Delivery in Tumours

**Authors:** Huiling Zuo, Yuhang Jiao, Jiaxin Chen, Sen Tong, Yan Li, Wei Zhao

PMC · DOI: 10.3390/gels12020098 · Gels · 2026-01-23

## TL;DR

This paper reviews smart hydrogels that release drugs in response to cancer-specific signals, offering a more precise and less harmful treatment option.

## Contribution

The paper provides a comprehensive review of recent advancements in stimulus-responsive hydrogels for targeted cancer drug delivery.

## Key findings

- Stimuli-responsive hydrogels can adapt to both endogenous and exogenous signals for controlled drug release.
- These hydrogels show improved efficacy in cancer treatment by minimizing adverse effects.
- Current limitations and future directions for smart hydrogels in drug delivery are discussed.

## Abstract

Cancer remains one of the most prominent global health concerns, posing a substantial threat to public health. Millions of people die from cancer each year, and many cancer types remain incurable at present. Conventional cancer treatments, including surgery, chemotherapy, radiotherapy, and immunotherapy, often fail to achieve optimal clinical outcomes and are frequently associated with severe trauma and adverse effects. Consequently, there is an urgent need to develop novel therapeutic strategies to address these limitations. Hydrogels have been widely utilised as platforms for loading drugs, proteins, DNA, and stem cells in biomedical tissue repair and cancer therapy. Through modification of their physicochemical properties and functions, hydrogels can be endowed with responsiveness to multiple stimuli. In recent years, stimuli-responsive hydrogels (also known as smart-responsive hydrogels), as novel drug delivery systems, have demonstrated remarkable efficacy in cancer treatment. Stimuli-responsive hydrogels are capable of altering their mechanical properties, swelling behaviour, hydrophilicity, bioactivity, and molecular permeability in response to endogenous stimuli (including pH, ROS, and temperature) and exogenous stimuli (including light, ultrasound, and magnetic fields). This review highlights recent advances and applications of responsive hydrogels triggered by endogenous stimuli (including pH, ROS, and temperature) and exogenous stimuli (including light, ultrasound, and magnetic force) in cancer drug delivery and treatment. Finally, the current application limitations and future prospects of smart-responsive hydrogels are summarised.

## Linked entities

- **Diseases:** cancer (MONDO:0004992)

## Full-text entities

- **Genes:** Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, Glb1 (galactosidase, beta 1) [NCBI Gene 12091] {aka Bge, Bgl, Bgl-e, Bgl-s, Bgl-t, Bgs}, CD274 (CD274 molecule) [NCBI Gene 29126] {aka ADMIO5, B7-H, B7H1, PD-L1, PDCD1L1, PDCD1LG1}, GLS (glutaminase) [NCBI Gene 2744] {aka AAD20, CASGID, DEE71, EIEE71, GAC, GAM}, Alb (albumin) [NCBI Gene 11657] {aka Alb-1, Alb1, BCL001, BCL002, BPL001}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, Mmp2 (matrix metallopeptidase 2) [NCBI Gene 17390] {aka Clg4a, GelA, MMP-2}, Pik3r1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 18708] {aka PI3K, p50alpha, p55alpha, p85alpha}, Cat (catalase) [NCBI Gene 12359] {aka 2210418N07, Cas-1, Cas1, Cs-1}, SPATA2 (spermatogenesis associated 2) [NCBI Gene 9825] {aka PD1, PPP1R145, tamo}
- **Diseases:** breast cancer (MESH:D001943), hepatocellular carcinoma (MESH:D006528), bladder cancer (MESH:D001749), glioblastoma (MESH:D005909), DDS (MESH:D000014), metastasis (MESH:D009362), infections (MESH:D007239), SDT (MESH:D016609), CDT (MESH:C537067), cytotoxic (MESH:D064420), hypoxic (MESH:D002534), autoimmune uveitis (MESH:D014605), neurological disorders (MESH:D009461), Hyperthermia (MESH:D005334), hypoxia (MESH:D000860), inflammation (MESH:D007249), osteosarcoma (MESH:D012516), neurodegenerative diseases (MESH:D019636), injury to (MESH:D014947), malignant melanoma (MESH:D008545), lung cancer (MESH:D008175), Cancer (MESH:D009369), atrophy (MESH:D001284)
- **Chemicals:** ATP (MESH:D000255), guar gum (MESH:C007894), maleimide (MESH:C043592), CS (MESH:D002586), glutamine (MESH:D005973), CO2 (MESH:D002245), GSH (MESH:D005978), lipid (MESH:D008055), PLA (MESH:C033616), PFH (MESH:C078626), dopamine (MESH:D004298), mPEG (MESH:C028210), PLGA (MESH:D000077182), glutaraldehyde (MESH:D005976), camptothecin (MESH:D002166), R837 (MESH:D000077271), cellulose (MESH:D002482), H+ (MESH:D006859), heparin (MESH:D006493), dexamethasone sodium phosphate (MESH:C004180), Ce6 (MESH:C062985), R848 (MESH:C402365), ROS (MESH:D017382), H2O2 (MESH:D006861), cisplatin (MESH:D002945), FeSAZ (-), NO (MESH:D009614), dextran (MESH:D003911), TAA (MESH:D013853), S-S (MESH:D013455), DOX (MESH:D004317), Disulfide (MESH:D004220), CA4 (MESH:C058728), peroxides (MESH:D010545), thiol (MESH:D013438), ZnPC (MESH:C063072), poly(vinyl alcohol) (MESH:D011142), CpG (MESH:C015772), poly (L-methionine) (MESH:C034757), methionine sulfoxide (MESH:C013111), urea (MESH:D014508), selenium (MESH:D012643), emodin (MESH:D004642), H2O (MESH:D014867), palladium (MESH:D010165), N-hydroxysuccinimide (MESH:C001426), copper sulfide (MESH:C017846), Schiff base (MESH:D012545), amide (MESH:D000577), adalimumab (MESH:D000068879), sodium diclofenac (MESH:D004008), hydrazone (MESH:D006835), cinnamaldehyde (MESH:C012843), poly(acrylic acid) (MESH:C006903), polydopamine (MESH:C568283), dithiothreitol (MESH:D004229), PVP (MESH:D011205), polylysine (MESH:D011107), Cu+ (MESH:D003300), acrylamide (MESH:D020106)
- **Species:** Staphylococcus aureus (species) [taxon 1280], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Homo sapiens (human, species) [taxon 9606], Escherichia coli (E. coli, species) [taxon 562], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** SMMC-7721 — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0534), 4T1 — Mus musculus (Mouse), Malignant neoplasms of the mouse mammary gland, Cancer cell line (CVCL_0125), MCF-7 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0031), A549 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12941131/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12941131/full.md

## References

192 references — full list in the complete paper: https://tomesphere.com/paper/PMC12941131/full.md

---
Source: https://tomesphere.com/paper/PMC12941131